These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9879813

  • 1. Mechanistic study on liver tumor promoting effects of piperonyl butoxide in rats.
    Okamiya H, Mitsumori K, Onodera H, Ito S, Imazawa T, Yasuhara K, Takahashi M.
    Arch Toxicol; 1998 Nov; 72(11):744-50. PubMed ID: 9879813
    [Abstract] [Full Text] [Related]

  • 2. Piperonyl butoxide induces hepatocellular carcinoma in male CD-1 mice.
    Takahashi O, Oishi S, Fujitani T, Tanaka T, Yoneyama M.
    Arch Toxicol; 1994 Nov; 68(7):467-9. PubMed ID: 7979964
    [Abstract] [Full Text] [Related]

  • 3. Chronic toxicity studies of piperonyl butoxide in F344 rats: induction of hepatocellular carcinoma.
    Takahashi O, Oishi S, Fujitani T, Tanaka T, Yoneyama M.
    Fundam Appl Toxicol; 1994 Feb; 22(2):293-303. PubMed ID: 7911767
    [Abstract] [Full Text] [Related]

  • 4. Chronic toxicity studies of piperonyl butoxide in CD-1 mice: induction of hepatocellular carcinoma.
    Takahashi O, Oishi S, Fujitani T, Tanaka T, Yoneyama M.
    Toxicology; 1997 Dec 26; 124(2):95-103. PubMed ID: 9457999
    [Abstract] [Full Text] [Related]

  • 5. Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats.
    Phillips JC, Price RJ, Cunninghame ME, Osimitz TG, Cockburn A, Gabriel KL, Preiss FJ, Butler WH, Lake BG.
    Fundam Appl Toxicol; 1997 Jul 26; 38(1):64-74. PubMed ID: 9268606
    [Abstract] [Full Text] [Related]

  • 6. Subacute toxicity of piperonyl butoxide in ICR mice.
    Fujitani T, Tanaka T, Hashimoto Y, Yoneyama M.
    Toxicology; 1993 Oct 25; 83(1-3):93-100. PubMed ID: 8248953
    [Abstract] [Full Text] [Related]

  • 7. Sub-acute toxicity of piperonyl butoxide in F344 rats.
    Fujitani T, Ando H, Fujitani K, Ikeda T, Kojima A, Kubo Y, Ogata A, Oishi S, Takahashi H, Takahashi O.
    Toxicology; 1992 Oct 25; 72(3):291-8. PubMed ID: 1585383
    [Abstract] [Full Text] [Related]

  • 8. Molecular pathological analysis for determining the possible mechanism of piperonyl butoxide-induced hepatocarcinogenesis in mice.
    Muguruma M, Nishimura J, Jin M, Kashida Y, Moto M, Takahashi M, Yokouchi Y, Mitsumori K.
    Toxicology; 2006 Dec 07; 228(2-3):178-87. PubMed ID: 17014948
    [Abstract] [Full Text] [Related]

  • 9. Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance.
    Lake BG, Price RJ, Scott MP, Chatham LR, Vardy A, Osimitz TG.
    Toxicology; 2020 Jun 07; 439():152465. PubMed ID: 32320717
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The relationship between decrease in Cx32 and induction of P450 isozymes in the early phase of clofibrate hepatocarcinogenesis in the rat.
    Shoda T, Mitsumori K, Onodera H, Toyoda K, Uneyama C, Imazawa T, Hirose M.
    Arch Toxicol; 1999 Sep 07; 73(7):373-80. PubMed ID: 10550479
    [Abstract] [Full Text] [Related]

  • 13. Estrogen and androgen receptor status in hepatocellular hypertrophy induced by phenobarbital, clofibrate, and piperonyl butoxide in F344 rats.
    Fujimoto N, Inoue K, Yoshida M, Nishikawa A, Ozawa S, Gamou T, Nemoto K, Degawa M.
    J Toxicol Sci; 2012 Sep 07; 37(2):281-6. PubMed ID: 22467018
    [Abstract] [Full Text] [Related]

  • 14. Oncogenicity studies of piperonyl butoxide in rats and mice.
    Butler WH, Gabriel KL, Osimitz TG, Preiss FJ.
    Hum Exp Toxicol; 1998 Jun 07; 17(6):323-30. PubMed ID: 9688356
    [Abstract] [Full Text] [Related]

  • 15. Liver tumor-promoting effect of beta-naphthoflavone, a strong CYP 1A1/2 inducer, and the relationship between CYP 1A1/2 induction and Cx32 decrease in its hepatocarcinogenesis in the rat.
    Shoda T, Mitsumori K, Onodera H, Toyoda K, Uneyama C, Takada K, Hirose M.
    Toxicol Pathol; 2000 Jun 07; 28(4):540-7. PubMed ID: 10930040
    [Abstract] [Full Text] [Related]

  • 16. Global DNA methylation screening of liver in piperonyl butoxide-treated mice in a two-stage hepatocarcinogenesis model.
    Yafune A, Kawai M, Itahashi M, Kimura M, Nakane F, Mitsumori K, Shibutani M.
    Toxicol Lett; 2013 Oct 09; 222(3):295-302. PubMed ID: 23968726
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carcinogenesis bioassay of technical-grade piperonyl butoxide in F344 rats.
    Cardy RH, Renne RA, Warner JW, Cypher RL.
    J Natl Cancer Inst; 1979 Mar 09; 62(3):569-78. PubMed ID: 283286
    [Abstract] [Full Text] [Related]

  • 19. Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide.
    Morita R, Yafune A, Shiraki A, Itahashi M, Akane H, Nakane F, Suzuki K, Shibutani M, Mitsumori K.
    J Toxicol Sci; 2013 Mar 09; 38(5):679-88. PubMed ID: 24025784
    [Abstract] [Full Text] [Related]

  • 20. Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats.
    Muguruma M, Unami A, Kanki M, Kuroiwa Y, Nishimura J, Dewa Y, Umemura T, Oishi Y, Mitsumori K.
    Toxicology; 2007 Jul 01; 236(1-2):61-75. PubMed ID: 17498859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.